173 related articles for article (PubMed ID: 21295812)
1. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice.
Liu SH; Smyth-Templeton N; Davis AR; Davis EA; Ballian N; Li M; Liu H; Fisher W; Brunicardi FC
Surgery; 2011 Apr; 149(4):484-95. PubMed ID: 21295812
[TBL] [Abstract][Full Text] [Related]
2. Liposomal insulin promoter-thymidine kinase gene therapy followed by ganciclovir effectively ablates human pancreatic cancer in mice.
Wu JX; Liu SH; Nemunaitis JJ; Brunicardi FC
Cancer Lett; 2015 Apr; 359(2):206-10. PubMed ID: 25596375
[TBL] [Abstract][Full Text] [Related]
3. Effective ablation of pancreatic cancer cells in SCID mice using systemic adenoviral RIP-TK/GCV gene therapy.
Liu SH; Davis A; Li Z; Ballian N; Davis E; Wang XP; Fisher W; Brunicardi FC
J Surg Res; 2007 Jul; 141(1):45-52. PubMed ID: 17512546
[TBL] [Abstract][Full Text] [Related]
4. Intravenous delivery of liposome-mediated nonviral DNA is less toxic than intraperitoneal delivery in mice.
Wang XP; Yazawa K; Templeton NS; Yang J; Liu S; Li Z; Li M; Yao Q; Chen C; Brunicardi FC
World J Surg; 2005 Mar; 29(3):339-43. PubMed ID: 15706434
[TBL] [Abstract][Full Text] [Related]
5. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy.
Tirone TA; Wang XP; Templeton NS; Lee T; Nguyen L; Fisher W; Brunicardi FC
World J Surg; 2004 Aug; 28(8):826-33. PubMed ID: 15457366
[TBL] [Abstract][Full Text] [Related]
6. A novel synthetic human insulin super promoter for targeting PDX-1-expressing pancreatic cancer.
Liu SH; Yu J; Sanchez R; Liu X; Heidt D; Willey J; Nemunaitis J; Brunicardi FC
Cancer Lett; 2018 Apr; 418():75-83. PubMed ID: 29309817
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
9. Specific targeting of pancreatic islet cells in vivo by insulin-promoter-driven adenoviral conjugated reporter genes.
Wang X; Olmsted-Davis E; Davis A; Liu S; Li Z; Yang J; Brunicardi FC
World J Surg; 2006 Aug; 30(8):1543-52. PubMed ID: 16855800
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic effect of multiple injections of HSV-TK + GCV gene therapy in combination with ionizing radiation in a mouse mammary tumor model.
Vlachaki MT; Chhikara M; Aguilar L; Zhu X; Chiu KJ; Woo S; Teh BS; Thompson TC; Butler EB; Aguilar-Cordova E
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1008-17. PubMed ID: 11704325
[TBL] [Abstract][Full Text] [Related]
11. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic carcinoma cell killing via adenoviral mediated delivery of the herpes simplex virus thymidine kinase gene.
Rosenfeld ME; Vickers SM; Raben D; Wang M; Sampson L; Feng M; Jaffee E; Curiel DT
Ann Surg; 1997 May; 225(5):609-18; discussion 618-20. PubMed ID: 9193188
[TBL] [Abstract][Full Text] [Related]
13. Construction of a novel oncolytic adenoviral vector and its biological characteristics.
Zhang M; Zhang X; Han Z; Chen X; Yang L; Sheng Y; Wen J
Oncol Rep; 2013 Feb; 29(2):798-804. PubMed ID: 23165979
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
15. GCV modulates the antitumoural efficacy of a replicative adenovirus expressing the Tat8-TK as a late gene in a pancreatic tumour model.
Cascante A; Abate-Daga D; Garcia-Rodríguez L; González JR; Alemany R; Fillat C
Gene Ther; 2007 Oct; 14(20):1471-80. PubMed ID: 17713568
[TBL] [Abstract][Full Text] [Related]
16. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies.
Vincent AJ; Esandi MC; Avezaat CJ; Vecht CJ; Sillevis Smitt P; van Bekkum DW; Valerio D; Hoogerbrugge PM; Bout A
Neurosurgery; 1997 Aug; 41(2):442-51; discussion 451-2. PubMed ID: 9257313
[TBL] [Abstract][Full Text] [Related]
17. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir.
Yang L; Hwang R; Pandit L; Gordon EM; Anderson WF; Parekh D
Ann Surg; 1996 Sep; 224(3):405-14; discussion 414-7. PubMed ID: 8813269
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of radiation-potentiated anti-angiogenic gene therapy against primary and metastatic cancer based on transcriptionally controlled HSV-TK.
Hodish I; Tal R; Shaish A; Varda-Bloom N; Greenberger S; Rauchwerger A; Breitbart E; Bangio L; Ben-Shushan D; Pfeffer R; Feder B; Waitsman A; Barshack I; Goldberg I; Mazaki-Tovi S; Peled M; Harats D
Cancer Biol Ther; 2009 Mar; 8(5):424-32. PubMed ID: 19276657
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral-mediated gene therapy for thyroid carcinoma using thymidine kinase controlled by thyroglobulin promoter demonstrates high specificity and low toxicity.
Zhang R; Straus FH; DeGroot LJ
Thyroid; 2001 Feb; 11(2):115-23. PubMed ID: 11288980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
